| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,752 |
1,606 |
$755K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,767 |
3,605 |
$506K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
380 |
338 |
$196K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
324 |
314 |
$56K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,305 |
2,868 |
$30K |
| 80053 |
Comprehensive metabolic panel |
2,470 |
2,235 |
$29K |
| 80061 |
Lipid panel |
765 |
747 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
231 |
205 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
680 |
659 |
$16K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
107 |
101 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
170 |
164 |
$13K |
| 87430 |
|
325 |
312 |
$13K |
| 87400 |
|
125 |
119 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
184 |
177 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
585 |
556 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
59 |
54 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
119 |
94 |
$7K |
| 81000 |
|
1,461 |
1,348 |
$6K |
| 82728 |
|
172 |
169 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
245 |
230 |
$3K |
| 87420 |
|
76 |
75 |
$2K |
| 81002 |
|
458 |
441 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
13 |
$2K |
| 83655 |
|
71 |
71 |
$2K |
| 83550 |
|
76 |
74 |
$1K |
| 85651 |
|
163 |
160 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
131 |
130 |
$791.36 |
| 83540 |
|
44 |
42 |
$645.16 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36 |
36 |
$606.24 |
| 84439 |
|
31 |
30 |
$576.13 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
26 |
$547.41 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
13 |
$463.81 |
| 87081 |
|
53 |
50 |
$449.16 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
78 |
70 |
$314.33 |
| 85027 |
|
25 |
25 |
$232.28 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
30 |
26 |
$196.22 |
| 85045 |
|
32 |
32 |
$187.75 |
| 81025 |
|
14 |
12 |
$178.75 |
| 84703 |
|
15 |
14 |
$140.97 |
| 85007 |
|
25 |
25 |
$136.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
94 |
69 |
$101.35 |
| 36415 |
Collection of venous blood by venipuncture |
3,980 |
3,495 |
$79.26 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
12 |
$45.30 |
| 83880 |
|
13 |
12 |
$16.73 |